Brian Shea
Nessuna posizione attualmente
Patrimonio netto: 1 076 $ in data 31/12/2023
Provenienza dei contatti di primo grado di Brian Shea
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Biotechnology | 16 | |
Ropes & Gray LLP
 Ropes & Gray LLP Miscellaneous Commercial ServicesCommercial Services Ropes & Gray LLP provides legal and private equity services. Its practice areas include asset management, banking, business and commercial litigation, business restructuring, capital markets and corporate governance and compliance. The company was founded in 1865 and is headquartered in Boston, MA.
8
| Holding Company | Miscellaneous Commercial Services | 8 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Brian Shea tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Comptroller/Controller/Auditor | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SAVICORP | Movies/Entertainment | Chief Tech/Sci/R&D Officer | |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| DICERNA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Chief Operating Officer | |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder Private Equity Investor | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Doctorate Degree | |
| SANOFI INDIA LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
ArcLight Capital Holdings LLC
 ArcLight Capital Holdings LLC Investment ManagersFinance ArcLight Capital Holdings LLC (ArcLight Capital) is a private equity firm founded by Dan R. Revers and Robb Eric Turner in 2000. The firm is headquartered in Boston, MA. | Investment Managers | Corporate Officer/Principal General Counsel | |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
| MODERNA, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO | |
Semma Therapeutics, Inc.
 Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director of Finance/CFO Director/Board Member | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| Babson College | College/University | Undergraduate Degree Masters Business Admin | |
| TURMERIC ACQUISITION CORP. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree | |
| University of Massachusetts | College/University | Masters Business Admin | |
LifeEDIT Therapeutics, Inc.
 LifeEDIT Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of ElevateBio LLC, LifeEDIT Therapeutics, Inc. is a next-generation genome editing company that has built a highly innovative platform with one of the world's largest and most diverse collections of novel RNA-guided nucleases (RGNs) and base editors. The company offers gene editing tools with higher fidelity, novel functionality, reduced immune response risk, and easier delivery. LifeEDIT has a large and diverse library of RGNs, including type II and type V systems that encompass knock-out and knock-in capabilities, transcriptional regulation, and base editing when coupled with one of their proprietary deaminases. The company's nuclease collection has a broad range of protospacer adjacent motifs (PAMs), offering unprecedented access to genomes. LifeEDIT is headquartered in Morrisville, NC. The CEO of the company is Mitchell H. Finer. LifeEDIT Therapeutics was acquired by ElevateBio LLC from AgBiome Delta LLC on October 27, 2021. | Miscellaneous Commercial Services | Chief Executive Officer | |
Longwood Fund Management LLC
 Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund Management) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Detwiler and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
| BIOMÉRIEUX | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Qualicaps, Inc.
 Qualicaps, Inc. Medical DistributorsDistribution Services Qualicaps, Inc. supplies capsule manufacturing equipment. It offers capsules equipment accessories, such as gelatin, nutritional, minicapsules, capsules filling equipment, and sealing equipment. The company also provides services like new product design, technical service, color formulation, capsule printing, and capsule samples. Qualicaps was founded in 1965 and is headquartered in Whitsett, NC. | Medical Distributors | Corporate Officer/Principal | |
| ELANCO ANIMAL HEALTH INCORPORATED | Biotechnology | Corporate Officer/Principal | |
Abata Therapeutics, Inc.
 Abata Therapeutics, Inc. BiotechnologyHealth Technology Abata Therapeutics, Inc. is a biotech company based in Watertown, MA. Abata Therapeutics is focused on developing engineered Treg cell therapies for severe autoimmune and inflammatory diseases. The American company's lead programs are in ind-enabling studies for progressive multiple sclerosis and type 1 diabetes, both of which are tissue-specific autoimmune diseases with significant unmet needs. The company has developed a differentiated product engine to create tissue-specific, robust, and durable therapies. Abata Therapeutics was launched by Third Rock Ventures, with participation from a diverse syndicate of investors, including ElevateBio, Lightspeed Venture Partners, Invus, Samsara Biocapital, and the JDRF T1D Fund. The company was founded in 2021 by Richard Ransohoff and the CEO is Samantha Singer. | Biotechnology | Director/Board Member | |
| CULLINAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| BLUEBIRD BIO, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Founder | |
| TCR2 THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
Intracel Holdings Corp.
 Intracel Holdings Corp. BiotechnologyHealth Technology Intracel Holdings Corp. engages in the development of vaccines and diagnostic products for cancer and infectious diseases. The company was founded in 2013 and is headquartered in Frederick, MD. | Biotechnology | Chief Executive Officer | |
| CANDEL THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
CODA Biotherapeutics, Inc.
 CODA Biotherapeutics, Inc. Medical SpecialtiesHealth Technology CODA Biotherapeutics, Inc. engages in the development of chemo genetic neuromodulation platform for the treatment of severe neurological disorders. The company was founded by Mitchell H. Finer, Allan Basbaum, Nicholas Boulis, Joseph Glorioso III and Kenneth P. Greenberg in 2014 and is headquartered in South San Francisco, CA. | Medical Specialties | Founder | |
ElevateBio LLC
 ElevateBio LLC BiotechnologyHealth Technology ElevateBio LLC is a biotechnology holding company, which creates and operates a broad portfolio of cell and gene therapy companies. It builds single and multi-product companies by providing scientific founders with bench-to-bedside capabilities including scientists, manufacturing facilities, drug developers, and commercial expertise. The company was founded by David L. Hallal, Vikas Sinha, and Mitchell H. Finer and is headquartered in Cambridge, MA. | Biotechnology | Founder |
Statistiche
Distribuzione geografica
| Stati Uniti | 41 |
| India | 2 |
| Francia | 2 |
Settori
| Health Technology | 30 |
| Consumer Services | 7 |
| Finance | 5 |
| Commercial Services | 3 |
| Distribution Services | 2 |
Posizioni
| Director/Board Member | 81 |
| Corporate Officer/Principal | 51 |
| President | 25 |
| Director of Finance/CFO | 20 |
| Independent Dir/Board Member | 20 |
Contatti più connessi
| Insiders | |
|---|---|
| Luke Evnin | 42 |
| Mitchell Finer | 26 |
| Craig Jalbert | 20 |
| Douglas Fambrough | 14 |
| Barbara Yanni | 13 |
| Theodore Ashburn | 10 |
| Spencer Nam | 10 |
| Mary Fenton | 10 |
| John McCabe | 10 |
| Richard J. Wanstall | 9 |
| Stephen Harbin | 9 |
| Eric Rubin | 7 |
| R. Stillwell | 7 |
| John Goldberg | 6 |
| Christina Kenny | 6 |
- Borsa valori
- Insiders
- Brian Shea
- Connessioni Società
